Nature of Business and Significant Accounting Policies - Schedule of Common Control and Ownership Interest (Details) (OWP Ventures, Inc.)

v3.19.2

Nature of Business and Significant Accounting Policies - Schedule of Common Control and Ownership Interest (Details) (OWP Ventures, Inc.)		6 Months Ended		9 Months Ended
		Jun. 30, 2019		Dec. 31, 2018
OWP Ventures, Inc. [Member]
Name of Entity	[1]			OWP Ventures, Inc.
State of Incorporation	[1]			DE
Relationship		Subsidiary	[2]	Parent	[1]
One World Pharma, Inc [Member]
Name of Entity	[3]			One World Pharma, Inc.
State of Incorporation	[3]			NV
Relationship		Parent	[4]	Subsidiary	[3]
One World Pharma S.A.S. [Member]
Name of Entity	[5]			One World Pharma S.A.S.
State of Incorporation	[5]			F8
Relationship		Subsidiary	[6]	Subsidiary	[5]
[1] Holding company in the form of a corporation as of December 31, 2018. [2] Holding company in the form of a corporation and wholly-owned subsidiary of One World Pharma, Inc. [3] Subsidiary as of December 31, 2018, following November 22, 2018 purchase of 66.2% of the issued and outstanding shares of One World Pharma, Inc. (f/k/a Punto Group, Corp.) by OWP Ventures, Inc. The shares were cancelled and returned to treasury pursuant to a merger on February 21, 2019, by a wholly-owned subsidiary of One World Pharma, Inc. with and into OWP Ventures, Inc. Following the merger, One World Pharma, Inc. is the parent company. [4] Holding company in the form of a corporation. [5] Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogota on July 18, 2017. Its sole headquarters is located in Bogota. [6] Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogota on July 18, 2017. Its headquarters are located in Bogota.